Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals - 1 Jun 2009

Ahirwar Dinesh K, Agrahari Anita, Mandhani Anil, Mittal Rama D

Abstract excerpt

The association of interleukin-1beta (IL-1B) -511C > T and IL-1 receptor antagonist (IL-1RN) VNTR, transforming growth factor-beta (TGF-B1) +28C > T and interferon-gamma (IFN-G) + 874T>A polymorphisms with bladder cancer (CaB) susceptibility and risk of recurrence in Bacillus Calmette-Guérin (BCG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BCG Vaccine
Share to Interferon-gamma
Share to Interleukin 1 Receptor Antagonist Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-1beta

Share to Minisatellite Repeats

Share to Recurrence

Share to Transforming Growth Factor beta

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 19489682
DOI: 10.1080/13547500902818246

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19489682-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy.PMID 19489682Read ↗

Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy.Semantic proximity Read ↗

IL-8 -251 T > A polymorphism is associated with bladder cancer susceptibility and outcome after BCG immunotherapy in a northern Indian cohort.Semantic proximity Read ↗

The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guérin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population.Semantic proximity Read ↗

Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.Semantic proximity Read ↗

Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in bladder cancer.Semantic proximity Read ↗

TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.Semantic proximity Read ↗

The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence.Semantic proximity Read ↗

Cytokine genotype polymorphisms in breast carcinoma: associations of TGF-beta1 with relapse.Semantic proximity Read ↗

The Role of Vitamin D Receptor Polymorphisms in Predicting the Response to Therapy for Nonmuscle Invasive Bladder Carcinoma.Semantic proximity Read ↗

TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients.Semantic proximity Read ↗

The association of cytokine gene polymorphism with reflux nephropathy.Semantic proximity Read ↗

Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.